• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AMA to Fast Track New CPT Code for Novel Coronavirus Test

Share:

March 18, 2020

Highlights on this story:
  • AMA announces it will fast track CPT code development for a novel coronavirus (COVID-19) test to bolster a data-driven response to the COVID-19 outbreak in the United States.
  • The CPT Editorial Panel will manage the expedited process including the creation of a test description to accompany the code and the effective date of the code.
  • According to the CDC, there is a total of 647 confirmed cases of COVID-19 resulting in 25 deaths in the United States.

To empower surveillance and laboratory testing in response to the spread of the novel coronavirus (SARS-CoV-2), the American Medical Association (AMA) announced a unique Current Procedural Terminology (CPT®) code for reporting novel coronavirus tests will be considered at a special CPT Editorial Panel meeting this week. If approved, the new CPT code will support the response to the urgent public health need for streamlined reporting of novel coronavirus testing offered by hospitals, health systems, and laboratories in the United States.

New Coronavirus CPT Code Timeline

The CPT Editorial Panel will manage the expedited process including the creation of a test description to accompany the code and the effective date of the code. The CPT Editorial Panel is an independent body convened by the AMA with the sole authority to manage revisions to the CPT code set.

Throughout the past several weeks, the AMA has worked closely with leaders at the Centers for Disease Control (CDC) and experts in the health care community to ensure the new CPT code meets the emergent demands for accurate reporting of a diagnostic test to detect the novel coronavirus.

Supporting a Data-Driven Response to COVID-19 Outbreak

“Moving as quickly as possible to put in place a CPT code for a novel coronavirus test will bolster a data-driven response to the COVID-19 outbreak in the United States,” said AMA President Patrice A. Harris, M.D., M.A. “By streamlining the flow of information on novel coronavirus testing, a new CPT code facilitates the reporting, measuring, analyzing, researching, and benchmarking that is necessary to help guide the nation’s response to the public health emergency.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The AMA will continue to keep physicians informed of the CDC’s resources and updates, including on the AMA’s COVID-19 online resource center and new Physicians Guide to COVID-19, via social media, and through direct communications to physicians.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Digital Health Firm Withings Carries Out Survey Into Its Users’ Health Behaviour Under LockdownDigital Health Firm Withings Carries Out Survey Into Its Users’ Health Behaviour Under Lockdown
  • Merck Delays Acceleron Deal Amidst Continuing Stakeholder CriticismMerck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism
  • Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of CancerTherapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer
  • Carrum Health, Florida Cancer Institute Partner to Expand Breast Cancer Care.Carrum Health, Florida Cancer Institute Partner to Expand Breast Cancer Care.
  • Roche Jumps into Lucrative Weight-Loss Space with $2.7B Carmot BuyRoche Jumps into Lucrative Weight-Loss Space with $2.7B Carmot Buy
  • Sparta Science Raises A New Round of Funding to Help Organizations Optimize Movement Health Outcomes at ScaleSparta Science Raises A New Round of Funding to Help Organizations Optimize Movement Health Outcomes at Scale
  • GraphPad Software Acquires SnapGene, Forms Insightful ScienceGraphPad Software Acquires SnapGene, Forms Insightful Science
  • Artificial intelligence: what we know so far about how it works for healthArtificial intelligence: what we know so far about how it works for health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications